Singapore markets open in 2 hours 24 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,266.73 +1,374.23 (+2.37%) CMC Crypto 200
1,280.41 +9.67 (+0.76%)
Roche Holding AG (RHHBF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:48PM EDT
| Previous close | 254.76 |
| Open | 259.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 259.00 - 259.00 |
| 52-week range | 243.42 - 354.00 |
| Volume | |
| Avg. volume | 213 |
| Market cap | 196.805B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 16.48 |
| EPS (TTM) | 15.72 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 10.86 (4.26%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.